1. Home
  2. CYTK vs AROC Comparison

CYTK vs AROC Comparison

Compare CYTK & AROC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYTK
  • AROC
  • Stock Information
  • Founded
  • CYTK 1997
  • AROC 1990
  • Country
  • CYTK United States
  • AROC United States
  • Employees
  • CYTK N/A
  • AROC N/A
  • Industry
  • CYTK Biotechnology: Pharmaceutical Preparations
  • AROC Oil & Gas Production
  • Sector
  • CYTK Health Care
  • AROC Energy
  • Exchange
  • CYTK Nasdaq
  • AROC Nasdaq
  • Market Cap
  • CYTK 4.6B
  • AROC 4.2B
  • IPO Year
  • CYTK 2004
  • AROC 1997
  • Fundamental
  • Price
  • CYTK $53.01
  • AROC $25.25
  • Analyst Decision
  • CYTK Buy
  • AROC Buy
  • Analyst Count
  • CYTK 15
  • AROC 6
  • Target Price
  • CYTK $75.57
  • AROC $30.00
  • AVG Volume (30 Days)
  • CYTK 2.6M
  • AROC 1.3M
  • Earning Date
  • CYTK 11-05-2025
  • AROC 08-04-2025
  • Dividend Yield
  • CYTK N/A
  • AROC 3.34%
  • EPS Growth
  • CYTK N/A
  • AROC 49.93
  • EPS
  • CYTK N/A
  • AROC 1.33
  • Revenue
  • CYTK $85,738,000.00
  • AROC $1,348,892,000.00
  • Revenue This Year
  • CYTK $330.96
  • AROC $31.31
  • Revenue Next Year
  • CYTK $73.41
  • AROC $6.91
  • P/E Ratio
  • CYTK N/A
  • AROC $18.96
  • Revenue Growth
  • CYTK 2635.74
  • AROC 28.23
  • 52 Week Low
  • CYTK $29.31
  • AROC $18.38
  • 52 Week High
  • CYTK $59.39
  • AROC $30.44
  • Technical
  • Relative Strength Index (RSI)
  • CYTK 77.96
  • AROC 60.50
  • Support Level
  • CYTK $35.22
  • AROC $24.24
  • Resistance Level
  • CYTK $50.22
  • AROC $24.99
  • Average True Range (ATR)
  • CYTK 2.29
  • AROC 0.59
  • MACD
  • CYTK 1.64
  • AROC 0.10
  • Stochastic Oscillator
  • CYTK 94.73
  • AROC 81.63

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

About AROC Archrock Inc.

Archrock Inc is an energy infrastructure company with a focus on midstream natural gas compression and a commitment to helping customers produce, compress, and transport natural gas. It has two business segments, Contract Operations, and Aftermarket Services. Under the umbrella of contract operations services, the company provides operations to meet customers' natural gas compression needs. Services include designing, owning, installing, operating, and maintaining equipment. Aftermarket Services business provides a full range of services to support the compression needs of customers who own compression equipment, including operations, maintenance, overhaul, and reconfiguration services, and sales of parts and components. It generates maximum revenue from the Contract Operations segment.

Share on Social Networks: